JP2016535762A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016535762A5 JP2016535762A5 JP2016544345A JP2016544345A JP2016535762A5 JP 2016535762 A5 JP2016535762 A5 JP 2016535762A5 JP 2016544345 A JP2016544345 A JP 2016544345A JP 2016544345 A JP2016544345 A JP 2016544345A JP 2016535762 A5 JP2016535762 A5 JP 2016535762A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- potato polysaccharide
- potato
- mammal
- polysaccharide preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000002595 Solanum tuberosum Nutrition 0.000 claims description 62
- 244000061456 Solanum tuberosum Species 0.000 claims description 62
- 150000004676 glycans Chemical class 0.000 claims description 58
- 229920001282 polysaccharide Polymers 0.000 claims description 58
- 239000005017 polysaccharide Substances 0.000 claims description 58
- 241000124008 Mammalia Species 0.000 claims description 21
- AGBQKNBQESQNJD-UHFFFAOYSA-N lipoic acid Chemical compound OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 claims description 6
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims description 6
- 230000037396 body weight Effects 0.000 claims description 5
- 206010012601 diabetes mellitus Diseases 0.000 claims description 5
- 208000010706 fatty liver disease Diseases 0.000 claims description 5
- 235000012015 potatoes Nutrition 0.000 claims description 4
- 208000024891 symptom Diseases 0.000 claims description 4
- 229940087168 alpha tocopherol Drugs 0.000 claims description 3
- 235000019136 lipoic acid Nutrition 0.000 claims description 3
- 229960002663 thioctic acid Drugs 0.000 claims description 3
- 229960000984 tocofersolan Drugs 0.000 claims description 3
- 235000004835 α-tocopherol Nutrition 0.000 claims description 3
- 239000002076 α-tocopherol Substances 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 238000000034 method Methods 0.000 description 30
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361879992P | 2013-09-19 | 2013-09-19 | |
| US61/879,992 | 2013-09-19 | ||
| PCT/US2014/053443 WO2015041837A1 (en) | 2013-09-19 | 2014-08-29 | Methods and materials for treating diabetes or liver steatosis |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016535762A JP2016535762A (ja) | 2016-11-17 |
| JP2016535762A5 true JP2016535762A5 (enExample) | 2017-09-14 |
| JP6535013B2 JP6535013B2 (ja) | 2019-06-26 |
Family
ID=52689269
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016544345A Expired - Fee Related JP6535013B2 (ja) | 2013-09-19 | 2014-08-29 | 糖尿病または肝臓脂肪症を処置する方法および物質 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US11160825B2 (enExample) |
| EP (1) | EP3046566B1 (enExample) |
| JP (1) | JP6535013B2 (enExample) |
| AU (1) | AU2014321711B2 (enExample) |
| CA (1) | CA2924597A1 (enExample) |
| WO (1) | WO2015041837A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3273970B1 (en) * | 2015-03-27 | 2020-10-07 | The Research Foundation for The State University of New York | Methods and materials for treating cancer |
| AU2016243516A1 (en) | 2015-03-27 | 2017-11-09 | The Research Foundation For The State University Of New York | Methods and materials for reducing amyloid beta levels within a mammal |
| WO2018052849A1 (en) | 2016-09-19 | 2018-03-22 | Mitogenetics, Llc | Materials and methods for producing and using mitochondrial preparations |
Family Cites Families (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2134714A (en) | 1936-11-25 | 1938-11-01 | Jacob A Glassman | Saccharine-aspirin tablet |
| US3622677A (en) | 1969-07-07 | 1971-11-23 | Staley Mfg Co A E | Compressed tablets containing compacted starch as binder-disintegrant ingredient |
| AU6141498A (en) | 1997-02-04 | 1998-08-25 | John V. Kosbab | Compositions and methods for prevention and treatment of vascular degenerative diseases |
| US20050085498A1 (en) * | 1998-05-28 | 2005-04-21 | Byrd Edward A. | Oral formulation of lipid soluble thiamine, lipoic acid, creatine derivative, and L-arginine alpha-ketoglutarate |
| US6376549B1 (en) * | 1998-09-17 | 2002-04-23 | Akesis Pharmaceuticals, Inc. | Metforimin-containing compositions for the treatment of diabetes |
| US20030159178A1 (en) | 2000-02-10 | 2003-08-21 | Peter Ulvskov | Method for remodelling cell wall polysaccharide structures in plants |
| US7590493B2 (en) | 2000-07-31 | 2009-09-15 | Ocimum Biosolutions, Inc. | Methods for determining hepatotoxins |
| DE10045059A1 (de) | 2000-09-12 | 2002-03-21 | Basf Ag | Therapeutische Kombination von Liponsäure und Konjuensäuren zur Behandlung diabetischer Störungen |
| EP1329452A1 (en) | 2000-10-20 | 2003-07-23 | Ajinomoto Co., Inc. | Medicinal compositions, dose and method for treating malaria |
| CA2450579A1 (en) | 2001-06-20 | 2003-01-03 | Merck & Co., Inc. | Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| GB0117767D0 (en) | 2001-07-20 | 2001-09-12 | Unilever Plc | Polymers and their synthesis |
| US20050031651A1 (en) | 2002-12-24 | 2005-02-10 | Francine Gervais | Therapeutic formulations for the treatment of beta-amyloid related diseases |
| WO2004069156A2 (en) | 2003-01-30 | 2004-08-19 | The Regents Of The University Of California | Inactivated probiotic bacteria and methods of use thereof |
| US20050214413A1 (en) | 2003-08-26 | 2005-09-29 | Mannatech, Inc. | Methods and compositions for modified release of nutritional supplements |
| US20050053664A1 (en) | 2003-09-08 | 2005-03-10 | Eliezer Zomer | Co-administration of a polysaccharide with a chemotherapeutic agent for the treatment of cancer |
| JP3998695B2 (ja) * | 2005-04-22 | 2007-10-31 | 株式会社シクロケム | αリポ酸水溶液及びその製造方法 |
| WO2006114019A1 (en) | 2005-04-26 | 2006-11-02 | Versitech Limited | Polysaccharide extract from lycium barbarum as neuroprotective agent against beta-amyloid peptide neurotoxicity |
| US7560536B2 (en) | 2005-05-18 | 2009-07-14 | Virginia Tech Intellectual Properties, Inc. | Morning glory-derived anticancer agents, and novel ipomoeassin compounds |
| JP4863204B2 (ja) * | 2005-06-15 | 2012-01-25 | 独立行政法人産業技術総合研究所 | 腎症関連疾患の診断方法及び診断キット |
| KR20070016520A (ko) * | 2005-08-04 | 2007-02-08 | 박옥순 | 황기청국장분말을 이용한 건강식품 |
| JP5247012B2 (ja) * | 2006-07-25 | 2013-07-24 | 雪印メグミルク株式会社 | 脂肪肝抑制剤 |
| WO2008087164A2 (en) * | 2007-01-18 | 2008-07-24 | Novozymes A/S | Method for producing potato products |
| JP2009007309A (ja) * | 2007-06-29 | 2009-01-15 | Riken Vitamin Co Ltd | α−リポ酸含有多芯型マイクロカプセル |
| KR101121543B1 (ko) | 2007-07-04 | 2012-03-06 | 학교법인 선목학원 | 벼과식물로부터 수득되는 전분 또는 식이섬유를 포함하는허혈성 질환 및 퇴행성 뇌질환의 예방 및 치료를 위한조성물 |
| US8569262B2 (en) | 2007-11-02 | 2013-10-29 | Momenta Pharmaceuticals, Inc. | Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization |
| US9078462B2 (en) * | 2009-10-02 | 2015-07-14 | University Of Idaho | Potato products with enhanced resistant starch content and moderated glycemic response and methods thereof |
| KR101093413B1 (ko) | 2009-10-05 | 2011-12-14 | 고려대학교 산학협력단 | 뇌 신경 세포 보호 활성을 갖는 고구마 추출물 및 그의 용도 |
| CN102762597A (zh) | 2009-12-11 | 2012-10-31 | 联合利华公众股份有限公司 | 适合调节免疫应答的多糖 |
| WO2012016050A2 (en) | 2010-07-28 | 2012-02-02 | The General Hospital Corporation | Chemoradiotherapy for kras-mutant colorectal cancer |
| JP2012149004A (ja) | 2011-01-18 | 2012-08-09 | Theravalues Corp | 核内受容体の賦活剤 |
| MX360979B (es) * | 2011-09-16 | 2018-11-22 | Galectin Therapeutics Inc | Composiciones de galacto-ramnogalacturonato para el tratamiento de la esteatohepatitis no alcohólica y de la enfermedad del higado graso no alcohólico. |
| WO2013067162A1 (en) | 2011-11-02 | 2013-05-10 | Synta Pharmaceuticals Corp. | Cancer therapy using a combination of hsp90 inhibitors with topoisomerase i inhibitors |
| WO2013148282A1 (en) * | 2012-03-28 | 2013-10-03 | The Research Foundation Of State University Of New York | Methods and materials related to nutritional supplement compositions containing a potato polysaccharide preparation |
| US9814255B2 (en) | 2012-05-20 | 2017-11-14 | Darco Natural Products Inc. | Method for producing purple sweet potato juice and dried powder |
| US9180212B2 (en) | 2012-05-22 | 2015-11-10 | The Regents Of The University Of California | β-amyloid plaque imaging agents |
| WO2014051076A1 (ja) | 2012-09-28 | 2014-04-03 | 株式会社Ｂｎａ | Ｂｎａクランプ法 |
| CN103110657A (zh) | 2013-01-31 | 2013-05-22 | 黄仁彬 | 玉郎伞多糖在制备药物中的应用 |
| US20170035917A1 (en) | 2013-06-10 | 2017-02-09 | Millennium Pharmaceuticals, Inc. | Methods of treatment of cancer |
| EP3273970B1 (en) | 2015-03-27 | 2020-10-07 | The Research Foundation for The State University of New York | Methods and materials for treating cancer |
| AU2016243516A1 (en) | 2015-03-27 | 2017-11-09 | The Research Foundation For The State University Of New York | Methods and materials for reducing amyloid beta levels within a mammal |
| US20190076461A1 (en) | 2016-03-14 | 2019-03-14 | Mitogenetics, Llc | Materials and methods for treating hypoxic conditions |
-
2014
- 2014-08-29 AU AU2014321711A patent/AU2014321711B2/en not_active Ceased
- 2014-08-29 EP EP14846523.0A patent/EP3046566B1/en not_active Not-in-force
- 2014-08-29 CA CA2924597A patent/CA2924597A1/en not_active Abandoned
- 2014-08-29 US US15/023,069 patent/US11160825B2/en active Active
- 2014-08-29 WO PCT/US2014/053443 patent/WO2015041837A1/en not_active Ceased
- 2014-08-29 JP JP2016544345A patent/JP6535013B2/ja not_active Expired - Fee Related
-
2021
- 2021-11-01 US US17/516,186 patent/US20220110965A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012021005A5 (enExample) | ||
| JP2016512248A5 (enExample) | ||
| JP2018527305A5 (enExample) | ||
| WO2011099832A3 (en) | Novel benzimidazole compound, preparation method thereof and pharmaceutical composition comprising the same | |
| HK1204271A1 (en) | Methods of reducing the risk of a cardiovascular event in a subject on statin therapy | |
| WO2011107749A3 (en) | Pulsatile drug release | |
| WO2014004861A3 (en) | Methods of treating pediatric metabolic syndrome | |
| JP2010531351A5 (enExample) | ||
| CN108026053A8 (zh) | 作为mIDH1抑制剂的稠合的咪唑类化合物 | |
| JP2014218522A5 (enExample) | ||
| JP2015131825A5 (enExample) | ||
| JP2016510326A5 (enExample) | ||
| MX2013010076A (es) | Composiciones y metodos que comprenden c16:1n7 palmitoleato. | |
| RU2019110980A (ru) | Фармацевтические композиции, содержащие 15-гэпк, и способы лечения астмы и заболеваний легких с их применением | |
| JP2016535762A5 (enExample) | ||
| Cernea et al. | Screening and interventions to prevent nonalcoholic fatty liver disease/nonalcoholic steatohepatitis-associated hepatocellular carcinoma | |
| JP2017514858A5 (enExample) | ||
| JP2016512247A5 (enExample) | ||
| WO2012106524A3 (en) | Diagnosis and treatment of the prodromal schizophrenic state | |
| EA201590474A1 (ru) | ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ НА ОСНОВЕ КОМПОЗИТНЫХ КАПСУЛ, ВКЛЮЧАЮЩИХ ИРБЕСАРТАН И ИНГИБИТОР ГМГ-КоА РЕДУКТАЗЫ | |
| RU2017129068A (ru) | Способ лечения или профилактики атеротромботических явлений у пациентов с инфарктом миокарда в анамнезе | |
| JP2016522188A5 (enExample) | ||
| JP2014533256A5 (enExample) | ||
| RU2015150303A (ru) | Композиция, содержащая гидрокортизон | |
| HK1245095A1 (zh) | 依维莫司(everolimus)与达托里昔布(dactolisib)的医药组合 |